Iterum Therapeutics plc (ITRMF) Net Margin (2017 - 2025)
Iterum Therapeutics (ITRMF) posted quarterly Net Margin of 2302.31% for Q3 2025, up 95.86% quarter-over-quarter from 55621.62% in Q1 2019.
Iterum Therapeutics plc (ITRMF) Net Margin (2017 - 2025) Analysis & Trends
Iterum Therapeutics' Net Margin history runs 4 years deep, the most recent figure standing at 2302.31% for Q3 2025.
- In Q3 2025, Net Margin changed N/A year-over-year to 2302.31%; the TTM figure through Sep 2025 stood at 6913.08% (changed N/A YoY), while the FY2019 annual figure was 278729.73%, down 26986253.0% from the prior year.
- Net Margin for Q3 2025 stood at 2302.31%, up from 55621.62% in the prior quarter.
- The five-year high for Net Margin was 2302.31% in Q3 2025, with the low at 2302.31% in Q3 2025.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -2,302.31% |
| Mar 31, 2019 | -55,621.62% |
| Dec 31, 2018 | -10,149.79% |
| Sep 30, 2018 | -9,805.12% |
| Jun 30, 2018 | -8,511.89% |
| Mar 31, 2018 | -6,359.16% |
| Dec 31, 2017 | -2,612.61% |
| Sep 30, 2017 | -5,138.99% |